XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Total Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
(In thousands)
Stock option expense$3,043 $2,768 $9,866 $10,017 
Restricted stock expense4,800 4,848 14,831 16,765 
Performance restricted stock unit expense4,217 3,812 9,890 8,239 
Total pre-tax expense$12,060 $11,428 $34,587 $35,021 
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Nine Months Ended
September 30, 2022
Year Ended December 31, 2021
Expected volatility24.5 %24.2 %
Expected term (years)5.05.0
Risk-free interest rate2.33 %0.85 %
Expected dividend yield0.65 %0.66 %
Black-Scholes-Merton fair value per stock option granted$32.54 $25.63 
Summary of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20213,352 $76.08 
Granted608 134.69 
Exercised(357)64.44 
Forfeited(101)107.73 
Outstanding at September 30, 20223,502 $86.52 6.2$110.4 
Exercisable at September 30, 20222,374 $72.84 5.0$97.8 
Summary of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2021413 $96.07 
Granted182 134.55 
Vested(156)86.31 
Forfeited(42)108.42 
Non-vested restricted stock outstanding at September 30, 2022397 $116.26 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2021289 $85.29 
Granted87 134.69 
Performance assumption change 1
66 81.76 
Vested(161)81.76 
Forfeited(6)98.07 
Non-vested performance restricted stock outstanding at September 30, 2022275 $101.98 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.